1. Home
  2. Philippe Herman
  3. Philippe Herman

Primary tabs

Search
Limit to
Export 72 results:
Filters: Author is Philippe Herman
2010
Methodology of the biological risk classification of animal pathogens in Belgium, Van Vaerenbergh, Bernadette, Koenen F., Pauwels Katia, Quanten K., Boyen F., Declercq K., Desmecht D., Thiry J., and Herman Philippe , 0/0/2010, Volume WIV-ISP Scientific Report 2008-2009, Number 140, Brussels, p.5, (2010)
Methodology of the biological risk classification of animal pathogens in Belgium, Van Vaerenbergh, Bernadette, Koenen F., Pauwels Katia, Quanten K., Boyen F., Declercq K., Desmecht D., Thiry J., and Herman Philippe , 0/0/2010, Volume 2008-2009, Number 140, Brussels, p.135 - 140, (2010)
Methodology of the biological risk classification of animal pathogens in Belgium., Van Vaerenbergh, B, Koenen F., Pauwels Katia, Quanten K, Boyen F, Declercq K, Desmecht D, Thiry J, and Herman Philippe , Rev Sci Tech, 2010 Dec, Volume 29, Issue 3, p.513-22, (2010)
New techniques of genetic modification and the GMO definition, Breyer, Didier, Pauwels Katia, and Herman Philippe , 0/0/2010, Volume WIV-ISP Scientific Report 2008-2009, Number 146, Brussels, p.144 - 146, (2010)
Sampling feasibility study of pathogenic organisms genetically modified or not in contained use activities, Leunda, Amaya, Pauwels Katia, Van Vaerenbergh Bernadette, and Herman Philippe , 0/0/2010, Volume D/2010/2505/19, Number 59, Brussels, p.59, (2010)
On state-of-the-art high biocontainment facilities in Belgium2772, Do Thi, Chuong Dai, Van Vaerenbergh Bernadette, Verheust C., and Herman Philippe , 0/0/2010, Volume WIV-ISP Scientific Report 2008-2009, Number 150, Brussels, p.147 - 150, (2010)
2009
Biological risk assessment sheets : Practical examples of risk assessment and biosafety recommendations for the contained use of genetically modified (micro-)organisms, Pauwels, Katia, Van Vaerenbergh Bernadette, Verheust C., and Herman Philippe , 0/0/2009, Volume D/2009/2505/48 , Number 22, Brussels, p.22, (2009)
Genetic modification through oligonucleotide-mediated mutagenesis. A GMO regulatory challenge?, Breyer, Didier, Herman Philippe, Brandenburger Annick, Gheysen Godelieve, Remaut Erik, Soumillion Patrice, Van Doorsselaere Jan, Custers René, Pauwels Katia, Sneyers Myriam, et al. , Environ Biosafety Res, 2009 Apr-Jun, Volume 8, Issue 2, p.57-64, (2009)
Inrichtingen met een hoog inperkingsniveau in België. Rapport: Periode 1995-2008, Do Thi, Chuong Dai, Van Vaerenbergh Bernadette, Herman Philippe, Pauwels Katia, Coppens Fanny, Leunda Amaya, and Verheust C. , 0/0/2009, Number 31, Brussels, p.31, (2009)
Les installations de haut niveau de confinement en Belgique. Rapport: Période 1995 - 2008, Do Thi, Chuong Dai, Van Vaerenbergh Bernadette, Herman Philippe, Pauwels Katia, Coppens Fanny, Leunda Amaya, and Verheust C. , 0/0/2009, Number 31, Brussels, p.31, (2009)
Should novel organisms developed using oligonucleotide-mediated mutagenesis be excluded from the EU Regulation, Breyer, Didier, Herman Philippe, Brandenburger A., Gheysen G., Remaut E., Soumillion P., Van Doorsselaere J., Custers R., Pauwels Katia, Sneyers Myriam, et al. , ISB news report, 0/0/2009, Volume November 2009, Number 12, Brussels, p.2 - 12, (2009)
State-of-the-art lentiviral vectors for research use: risk assessment and biosafety recommendations., Pauwels, Katia, Gijsbers Rik, Toelen Jaan, Schambach Axel, Willard-Gallo Karen, Verheust Céline, Debyser Zeger, and Herman Philippe , Curr Gene Ther, 2009 Dec, Volume 9, Issue 6, p.459-74, (2009)
2008
Emploi d'appareils de protection respiratoire durant l'utilisation confinée d'organismes génétiquement modifiés et/ou pathogènes, Pauwels, Katia, Coppens Fanny, Verheust C., Van Vaerenbergh Bernadette, Do Thi Chuong Dai, and Herman Philippe , 0/0/2008, Volume D/2008/2505/01, Number 27, Brussels, p.27, (2008)
2007
Gebruik van ademhalingsbeschermingsmiddelen bij het ingeperkt gebruik van genetisch gemodificeerde organismen en/of pathogenen, Pauwels, Katia, Coppens Fanny, Verheust C., Van Vaerenbergh Bernadette, Do Thi Chuong Dai, and Herman Philippe , 0/0/2007, Volume 2007/2505/64, Number 28, Brussels, p.28, (2007)
2006
Biosafety recommendations for the contained use of Mycobacterium tuberculosis complex isolates in industrialized countries, Herman, Philippe, Fauville M., Breyer Didier, Van Vaerenbergh Bernadette, Pauwels Katia, Do Thi Chuong Dai, Sneyers Myriam, Wanlin M., Snacken R., and Moens William , 0/0/2006, Volume D/2006/2505/22, Number 17, Brussels, p.17, (2006)
Bioveiligheidsaanbevelingen aangaande behandelings- en inactiveringsmethoden voor biologisch besmet afval, Berghmans, L., Pauwels Katia, Van Vaerenbergh Bernadette, Do Thi Chuong Dai, and Herman Philippe , 0/0/2006, Volume D/2006/2505/28, Number 33, Brussels, p.33, (2006)
Enceintes de sécurité microbiologique, Herman, Philippe, and Pauwels Katia , 0/0/2006, Volume D/2006/2505/20, Number 15, Brussels, p.15, (2006)
Microbiologische veiligheidswerkkasten, Herman, Philippe, and Pauwels Katia , 0/0/2006, Volume D/2006/2505/20, Number 15, Brussels, p.15, (2006)
Negatieve luchtdruk bij L3 laboratoria, Pauwels, Katia, Van Vaerenbergh Bernadette, Do Thi Chuong Dai, Berghmans L., and Herman Philippe , 0/0/2006, Volume D/2006/2505/15, Number 6, Brussels, p.6, (2006)
Pression de l'air négative dans les laboratoires L3, Pauwels, Katia, Van Vaerenbergh Bernadette, Do Thi Chuong Dai, Berghmans L., and Herman Philippe , 0/0/2006, Volume D/2006/2505/15, Number 6, Brussels, p.6, (2006)
Recommandations de biosécurité relatives au traitement et aux méthodes d'inactivation des déchets biologiques contaminés, Berghmans, L., Pauwels Katia, Van Vaerenbergh Bernadette, Do Thi Chuong Dai, and Herman Philippe , 0/0/2006, Volume D/2006/2505/33, Number 33, Brussels, p.33, (2006)
2004
Biosafety risk assessment of the Severe Acute Respiratory Syndrome (SARS) coronavirus and containment measures for the diagnostic and research laboratories, Herman, Philippe, Verlinden Y., Breyer Didier, Van Cleemput E., Brochier Bernard, Sneyers Myriam, Snacken R., Hermans P., Kerkhofs Pierre, Liesnard C., et al. , Appl.Biosaf., 0/0/2004, Volume 9, Issue 3, Number 142, p.128 - 142, (2004)

QR code

QR code for this page URL